Answer
Ceftobiprole medocaril sodium may increase concentrations of pitavastin, pravastatin and rosuvastatin through inhibition of OATP1B1 and OATP1B3, based on in vitro findings; no clinical interaction studies have been performed.
Sources for this answer
- Zevtera 500 mg powder for concentrate for solution for infusionADVANZ Pharma · emc · SmPC §4.5 Interaction with other medicinal products · Version 9Document updated
Sources checked